ROARABLE
FREE $100K
Today Screener Big Ideas Track Record πŸ’° $100K Arena 🎲 Predictions πŸ›οΈ Insiders 8 Analysts
Stock Ratings / Health Care / APT / insiders
COCH (36) MYO (31) NTRB (37) CNXU (43) ⌘ Pro Terminal β†’

Alpha Pro Tech Ltd. (APT) Insider, 13F Hedge Fund & Politician Buy/Sell Thermometer

$5.40 -2.70% NYSE β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $5.36

Alpha Pro Tech Ltd. (APT) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

ROARABLE C- β€’ HOLD / WATCH Cap $55.1M
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on APT Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is APT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Alpha Pro Tech Ltd. (NYSE: APT) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $5.40 (-2.70% 1D, market cap $55.1M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 8/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 13/20. Across 1015 tracked Health Care issuers, APT ranks #159 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does APT compare to COCH and MYO in the Health Care sector?
β–Ό

Within the Health Care sector (Industrial Specialties), APT carries a Roarable C- (61/100 RQD), trailing P/E of 16.2x, gross margin of 38.1%, and ROIC of 6.7%. By comparison, COCH (Envoy Medical Inc. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $51.3M) and MYO (Myomo Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $49.1M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for APT?
β–Ό

Per APT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884269), Alpha Pro Tech Ltd. generated $59.1M in revenue (+2.3% YoY), $3.5M in net income, and $1.7M in free cash flow against $74.1M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $5.36 (-0.68%)🧬 Cannibal Buyback (-1.52% YoY Shares)βš™οΈ Cash Engine: 11/20 (D+) β€’ 2.9% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record: Scores of 61/100 (C-) historically posted market-perform odds over rolling 90-day windows (+0.5% avg 90D alpha vs SPY β€’ 53.9% hit rate β€” wait for RQD β‰₯ 70 breakout).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERHOLD / WATCH β€’ C-
025507510061
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D+ Β· Rk B
Cash (11)Whales (8)SEC (16)Macro (13)CEO (13)
Each axis scored 0–20
12M PRICE TARGET CONE+1.3% Base Target
$8 Bull$5 Base$4 Bear
πŸ“¬ FREE APT RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for APT)Realized 20D OHLCV Swing Band: Β±7.7%
Deterministic 5-Pillar Attribution (61/100 Composite)
πŸ” WHY APT SCORES 61/100 (C-) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: SEC 10-K Forensic Risk+16/20 pts (26% of score)

Altman Z-Score 5.59 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 5/9

β–² #2 Bullish Driver: Macro Regime Fit+13/20 pts (21% of score)

FRED Regime Γ— Technicals: 34% of 52W Range β€’ RSI-14 at 46.9 (NEUTRAL RANGE)

β–Ό #1 Drag / Risk Factor: Whale & Options Positioning8/20 pts (-12 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-12 pts vs max)

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
69
Grade B-$5.76-3.5% Next Q
Q2 (-2Q)
66
Grade B-$5.56-2.2% Next Q
Q3 (-1Q)
64
Grade C+$5.44-0.7% Next Q
Current
61
Grade C-$5.40+0.5% Hist 90D Ξ±
Trajectory: B- (69) β†’ C- (61)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

βš”οΈ Adversarial Opposing Case: Why the APT Bull Thesis Could Fail

Gideon Ashmere Forensic Desk β†’

Even with a 61/100 (C-) score, APT faces multiple-compression risk if 16.2x trailing P/E re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Broader market pullbacks can still drag down strong stocks in the short run.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.52% YoY Shares) β€” any gross margin slip below 35.6% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($5.40) or 200D SMA ($5.20) invalidates the momentum regime and cuts Target Base ($5.47) toward Bear Floor ($4.27).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $APTβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œAPT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
YES 61%NO 39%Trade / Inspect Odds β†’
SEC FORM 4 Γ— 13F HEDGE FUNDS Γ— CONGRESSIONAL STOCK ACT

APT Smart-Money Thermometer: HEAVY INSIDER & 13F ACCUMULATION

Explore All 13F & Congress Whales β†’
β–² Disclosed Buys: 0 ($0)β–Ό Disclosed Sales: 0 ($0)

Wide-Open SEC Form 4, 13F & Congressional Disclosure Ledger (APT)

No recent open-market Form 4 cluster sales or emergency dumps flagged on APT. Visit the Global 13F & Congressional Whale Ledger for cross-market smart-money filings.

ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Quantitative Research Desk

Scheduled RQD Strong Buys & Whale Accumulation Briefing (APT Tape Review)

  • βœ“Breakdown of the highest-scoring RQD Green-Light breakouts across our 5,200+ rated universe
  • βœ“Forensic Red-Light accounting & dilution traps to review on your watchlist
  • βœ“Includes downloadable .ics calendar invite & nightly RQD rating-change email alerts
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) β†’$100K Arena
APT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +17.39%β–² ASCENDING CHANNEL
2026-11-03O $5.55H $5.55L $5.40C $5.40VOL 29.2K
RES: $6.51SUP: $5.07SMA50: $5.40SMA200: $5.20
$7.71$6.85$6.00$5.15$4.30RES $6.51SUP $5.07$5.402026-05-042026-06-172026-08-042026-09-182026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

APT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

πŸ¦‹ APT Butterfly Map β†’ + Track APT β†’
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.8%/yr Implied 5Y Growth

vs. +2.3% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on APT today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for APT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for APT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (APT)

Health Care Rank #159 of 1015 βš”οΈ COCH vs APT Full Matrix β†’

1. Head-to-Head Health Care Peer Comparison (APT vs. COCH, MYO, NTRB, CNXU)

Industry: Industrial Specialties (55 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Alpha Pro Tech Ltd. (APT) ranks #159 by composite RQD confidence (61/100, grade C-) and #727 by equity capitalization ($55.1M). Within this direct 5-issuer industry benchmark cohort, APT leads on earnings valuation at 16.2x trailing P/E, while APT leads on capital efficiency and profitability with 6.7% ROIC and 38.1% gross margin. APT currently leads its immediate peer cohort in composite quantitative strength at 61/100 (C-).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
APT ACTIVE
Alpha Pro Tech Ltd.
C- 61/100 16.2x 38.1% 6.7% -2.70% $55.1M Benchmark Subject
COCH
Envoy Medical Inc. (Class A)
D- 36/100 β€” -30.0% -35.0% +2.00% $51.3M /coch-vs-apt β†’
MYO
Myomo Inc.
E 31/100 β€” 65.7% -35.0% -4.61% $49.1M /myo-vs-apt β†’
NTRB
Nutriband Inc.
D- 37/100 β€” 27.8% -35.0% -5.12% $76.6M /ntrb-vs-apt β†’
CNXU
Conexeu Sciences Inc.
D- 43/100 β€” β€” β€” -10.25% $77.0M /cnxu-vs-apt β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0000884269 β†—

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Alpha Pro Tech Ltd. (APT) reported GAAP revenue of $59.1M (+2.3% vs. FY2024 revenue of $57.8M , and +411.2% cumulative change since FY2023) , GAAP net income of $3.5M, operating cash flow of $2.4M, and free cash flow of $1.7M (-8.5% YoY). On the balance sheet, APT closed FY2025 with $74.1M in total assets against $0 in total debt (Altman Z-Score: 5.59, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $59.1M $3.5M $2.4M $1.7M $74.1M β€”
FY2024 (FY) 2024-12-31 $57.8M $3.9M $5.7M $1.9M $73.7M β€”
FY2023 (FY) 2023-12-31 $11.6M $4.2M $8.5M $8.5M β€” β€”

3. APT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is APT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Alpha Pro Tech Ltd. (NYSE: APT) is rated C- (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 61/100 at a spot price of $5.40 (-2.70% 1D, market cap $55.1M). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 8/20, SEC Balance-Sheet Forensics 16/20, FRED Macro Regime Fit 13/20, and Executive Insider Alignment 13/20. Across 1015 tracked Health Care issuers, APT ranks #159 in composite RQD confidence.

How does APT compare to COCH and MYO in the Health Care sector?

Within the Health Care sector (Industrial Specialties), APT carries a Roarable C- (61/100 RQD), trailing P/E of 16.2x, gross margin of 38.1%, and ROIC of 6.7%. By comparison, COCH (Envoy Medical Inc. (Class A)) holds a D- grade (36/100 RQD, P/E N/A, ROIC -35.0%, cap $51.3M) and MYO (Myomo Inc.) posts a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $49.1M). Among the 5-stock peer group, APT leads on earnings multiple (16.2x) while APT leads on capital efficiency (6.7% ROIC).

What are the biggest fundamental strengths and SEC risk factors for APT?

Per APT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0000884269), Alpha Pro Tech Ltd. generated $59.1M in revenue (+2.3% YoY), $3.5M in net income, and $1.7M in free cash flow against $74.1M in total assets and $0 in total debt. Key quantitative strengths: Clean SEC annual filing review with no major hidden accounting time-bombs. Primary risk factors monitored: Broader market pullbacks can still drag down strong stocks in the short run. Institutional options positioning shows a 50% call / 50% put premium split.

Where is APT trading relative to its 50-day, 200-day, and 52-week technical levels?

APT last traded at $5.40 (-2.70% on volume of 29,207 shares), positioning the stock 0.00% above its 50-day simple moving average ($5.40) and +3.85% above its 200-day simple moving average ($5.20). Across its 52-week range of $4.34 to $7.50, APT sits at the 33.5% percentile with a 14-day RSI of 46.9 (NEUTRAL RANGE) and an implied next-earnings move of Β±7.7% ($4.98 to $5.82).

Direct Sub-Reports: APT RQD Cockpit APT 12M Forecast APT Earnings & Move APT Dividends & DRIP APT Insiders & 13F APT Whale Options APT Profit Sankey APT News & Why
ROARABLE RATING BRIEF β€’ RQD 61/100 (C-) βœ“ SEC XBRL & RQD VERIFIED

APT β€” Alpha Pro Tech Ltd.: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2025-12-31

1. Roarable Rating Brief: What This Means to a Prospective Investor

Alpha Pro Tech Ltd. (APT) earns a live Roarable RQD composite score of 61/100, corresponding to a C- letter grade (Roarable Hold) at a spot price of $5.40 (-2.70% 1D, market capitalization $55.1M).

  • Fundamental Cash Engine (11/20): Anchored by return on invested capital (ROIC) of 6.7%, gross margin of 38.1%, operating margin of 6.5%, and free cash flow yield of 3.06%.
  • Whale 13F & Options Flow (8/20) + Insider Conviction (13/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (13/20) + Forensic Balance Sheet (16/20): Incorporates a 1.00x equity beta, Altman Z-Score of 5.59, Piotroski F-Score of 5/9, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Alpha Pro Tech Ltd. (APT) is a NYSE-listed issuer classified in the Health Care sector and the Industrial Specialties industry,. Per the market data, gross margin is 38.1%.

In its latest audited SEC EDGAR 10-K filing for FY2025 (filed 2025-12-31), Alpha Pro Tech Ltd. (APT) reported $59.1M in annual revenue (up from $57.8M in FY2024, +2.3% YoY) and $3.5M in GAAP net income. Over the multi-year SEC filing window from FY2023 ($11.6M revenue, $4.2M net income) through FY2025, APT scaled operating cash flow to $2.4M and free cash flow to $1.7M, backed by $74.1M in total assets against $0 in total debt.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case (C- β€’ RQD 61/100): Clean SEC annual filing review with no major hidden accounting time-bombs. Free cash flow yield of 3.06% and institutional whale pillar of 8/20. With Fundamental Cash Engine at 11/20 and Institutional Whale Flow at 8/20, sustained execution supports upside toward the upper end of the $4.34 – $7.50 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Broader market pullbacks can still drag down strong stocks in the short run. Investors must weigh 16.2x trailing P/E and 9.0x EV/EBITDA against 6.5% operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

Upstream suppliers, downstream customers, and sector correlations are β€” A prospective investor should monitor whether future filings identify key input suppliers or concentrated customers, since no second-order exposures can be mapped from the current data.

  • Key Question #1: Can APT sustain or expand its 6.5% operating margin and 6.7% ROIC against Industrial Specialties peers over the next 4 quarters?
  • Key Question #2: Following FY2025 revenue of $59.1M and free cash flow of $1.7M, how will capital allocation balance growth reinvestment against $0 in total debt?
  • Key Question #3: How sensitive is APT's 15.1x forward P/E multiple to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

APT Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Alpha Pro Tech Ltd. (APT) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to APT Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

APT Bull vs. Bear Conversation Board β€” What's Your Call at $5.40?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON APT 🐻 33% BEARISH CONVICTION
1. Pick Your Side on APT:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
TA TapeReader_Pro RQD DEBATE OPENER β€’ Price Action & Volume Trader πŸ‚ BULLISH 🎯 Target: $6.37 (+18.0%)
πŸ“Œ Pinned Debate

A 16 forensic-balance-sheet pillar score, Altman Z of 5.59, and Debt/Equity of 0.5 point to a financially resilient balance sheet at a

Here is why I am bullish on APT here at $5.40: A 16 forensic-balance-sheet pillar score, Altman Z of 5.59, and Debt/Equity of 0.5 point to a financially resilient balance sheet at a P/E of 16.2.. Compare APT's 6.5% operating margin and 6.7% ROIC against the rest of Industrial Specialties. As long as cash conversion holds up, dips toward $5.13 are getting bought.

RetailWhale_TX πŸ‚ BULL

@MeanReversion_88 Shorting a 8/20 institutional whale-flow stock at $5.40 is dangerous when funds are rotating into Health Care.

ME MeanReversion_88 RQD DEBATE OPENER β€’ Quantitative Statistical Arb 🐻 BEARISH 🎯 Target: $4.48 (-17.0%)
Spot @ $5.40

A 9 of 20 whale 13F flow score and ROIC of 6.7% indicate weak institutional conviction and modest returns on capital.

I respect the product at Alpha Pro Tech Ltd., but the stock at $5.40 is a different story. A 9 of 20 whale 13F flow score and ROIC of 6.7% indicate weak institutional conviction and modest returns on capital.. FCF yield is 3.06% and RQD sits at 61/100 (C-) β€” why pay up here when you can wait for next quarter's numbers?

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $204.64 -4.22% AAPL $344.63 -1.23% MSFT $521.91 -1.55% TSLA $399.81 -0.86% PLTR $184.11 -6.27% SOFI $16.76 -4.83% IBIT $43.35 -5.42% GLD $361.65 -3.59%